jump to search box

Rational and combinatorial engineering of the met and axl receptor systems [electronic resource] / Douglas Scott Jones, II.

Availability

Online

At the Library

Other libraries

Author/Creator:
Jones, Douglas Scott, II.
Language:
English
Imprint:
2010, c2011.
Format:
  • Book, Thesis
  • 1 online resource.
Note:
Submitted to the Department of Bioengineering.
Note:
Thesis (Ph.D.)--Stanford University, 2011.
Summary:
Ligand-receptor interactions govern nearly all cellular processes, and dysregulation leads to a range of diseases including cancer, autoimmune diseases, and regenerative disorders. As such, new strategies to target ligand-receptor interactions for therapeutic applications are an important area of research. To develop enhanced agonists and antagonists of the Met receptor, a critical target in cancer therapy and regenerative medicine, we engineered a fragment of the natural activating ligand (termed NK1). First, NK1 was evolved for improved stability using directed evolution. Then, using the activation mechanism of Met by NK1, the resulting enhanced stability mutants were rationally engineered for either agonistic or antagonistic activity. Next, the rationally engineered mutants were used as 'molecular tools' to provide further insights into NK1 structure and function. Finally, these insights supported additional rational engineering to generate further enhanced agonistic proteins. The antagonistic and agonistic proteins developed in this thesis hold promise as cancer therapeutics and diagnostics or for regenerative medicine applications, respectively. This work also supports native ligands as a promising starting point for development of therapeutic proteins.
Contributor:
Cochran, Jennifer R., primary advisor.
Giaccia, Amato J., advisor.
Khosla, Chaitan, 1964- advisor.
Swartz, James R., advisor.
Stanford University. Department of Bioengineering.

powered by Blacklight
© Stanford University. Stanford, California 94305. (650) 725-1064. Terms of Use | Copyright Complaints | Opt Out of Analytics
jump to top